{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:09:39Z","timestamp":1787008179372,"version":"build-2736575974"},"reference-count":75,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cachexia is a prevalent condition associated with underlying chronic disease. Wasting of skeletal muscle and adipose tissue loss in cachectic patients is associated with higher rates of disability, reduced quality of life (QoL), and worse prognosis. There is a large unmet need to develop strategies to treat cachexia as there are currently no standardized guidelines in the management of cachexia. Activation of endogenous cannabinoid receptors, through exogenous cannabinoids, has demonstrated potential in increasing appetite, reducing catabolism, and has shown anti-inflammatory properties. Since no single pharmacological agent is currently recommended for use in cachexia, the potential of cannabinoids as an appetite stimulant warrants further research and assessment of current evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This review aims to evaluate the evidence for the efficacy of cannabis-based medicinal products, against placebo and other active treatments, in anorexia\u2013cachexia syndrome in improving appetite, weight, and QoL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A literature search of the Medline, EMBASE, CENTRAL, and the Web of Science Core Collection, for articles published up to February 2020, was conducted. All randomized controlled trials comparing the use of cannabis-based medicine versus placebo\/active treatments for patients with cachexia were screened. The quality of evidence in included studies was assessed using the GRADE framework and any risk of bias was judged using the Cochrane risk of bias tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of five studies, encompassing 934 participants, were found to be eligible. The pooled group effect size for change in appetite was \u22121.79 (95% confidence interval: \u22123.77 to 0.19) favoring the control group (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.08). Additionally, no significant difference for weight change or change in QoL for cannabinoids versus placebo\/other treatment was observed. The quality of evidence for all five studies was assessed to be low.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>There is a lack of high-quality evidence to recommend the use of cannabinoids in the treatment of cachexia. Given the limited available pharmacological options for cachexia and the potential for cannabinoids to increase appetite and alter the immune system, further research is needed before clinical recommendations on the pharmacological management of cachexia can be made.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/can.2021.0048","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T13:04:58Z","timestamp":1634648698000},"page":"474-487","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":27,"title":["The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis"],"prefix":"10.1177","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0188-9940","authenticated-orcid":false,"given":"Samuel","family":"Hammond","sequence":"first","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, Academic Surgical Unit, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-6501","authenticated-orcid":false,"given":"Simon","family":"Erridge","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, Academic Surgical Unit, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagina","family":"Mangal","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Hammersmith Hospital, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pacchetti","sequence":"additional","affiliation":[{"name":"Curaleaf International, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael H.","family":"Sodergren","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, Academic Surgical Unit, London, United Kingdom."},{"name":"Curaleaf International, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2008.06.013"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-010-0002-6"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/83.4.735"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-014-0164-8"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-013-0105-y"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3795-2"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-014-0142-1"},{"key":"e_1_3_5_9_2","first-page":"3473","article-title":"Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients\u2014Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study","volume":"24","author":"Takayama K","year":"2016","unstructured":"Takayama K, , Atagi S, , Imamura F, et al. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients\u2014Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study. Support Care Cancer. 2016; 24:3473\u20133480.","journal-title":"Support Care Cancer"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12220"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07015-8"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-012-0075-5"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-013-0111-0"},{"key":"e_1_3_5_14_2","first-page":"3792","article-title":"Cancer cachexia is associated with decreased responsiveness of immune cells to immunomodulatory cytokines","volume":"68","author":"Lesinski G","year":"2008","unstructured":"Lesinski G, , Young G, , Brasdovich M, et al. Cancer cachexia is associated with decreased responsiveness of immune cells to immunomodulatory cytokines. Cancer Res. 2008; 68(9 Supplement):3792.","journal-title":"Cancer Res"},{"key":"e_1_3_5_15_2","first-page":"753","article-title":"Malnutrition and the heart","volume":"135","author":"Webb JG","year":"1986","unstructured":"Webb JG, , Kiess MC, , Chan-Yan CC. Malnutrition and the heart. Can Med Assoc J. 1986; 135:753\u2013758.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/107602960401000412"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/030089168907500223"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/73.4.673"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200420174"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.01874"},{"key":"e_1_3_5_21_2","first-page":"2363","article-title":"NF-\u03baB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia","volume":"289","author":"Guttridge DC","year":"2000","unstructured":"Guttridge DC, , Mayo MW, , Madrid LV, et al. NF-\u03baB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. SCIEAS. 2000; 289:2363\u20132366.","journal-title":"SCIEAS"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910610123"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2011.25"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0787-0"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mco.0000078989.18774.74"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2006.1863"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2015.07.007"},{"issue":"1","key":"e_1_3_5_28_2","first-page":"S9","article-title":"The endocannabinoid system: mechanisms behind metabolic homeostasis and imbalance","volume":"120","author":"Woods SC","year":"2007","unstructured":"Woods SC. The endocannabinoid system: mechanisms behind metabolic homeostasis and imbalance. AM J Clin Med. 2007; 120(2 Suppl 1):S9\u2013S32.","journal-title":"AM J Clin Med"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12273"},{"key":"e_1_3_5_30_2","first-page":"1","article-title":"Medical cannabinoids for cancer cachexia: a systematic review and meta-analysis","volume":"2019","author":"Wang J","year":"2019","unstructured":"Wang J, , Wang Y, , Tong M, et al. Medical cannabinoids for cancer cachexia: a systematic review and meta-analysis. BioMed Res Int. 2019; 2019:1\u20136.","journal-title":"BioMed Res Int"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.6358"},{"key":"e_1_3_5_32_2","first-page":"305","article-title":"Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain","volume":"2","author":"Martin BR","year":"2004","unstructured":"Martin BR, , Wiley JL. Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain. J Support Oncol. 2004; 2:305\u2013316.","journal-title":"J Support Oncol"},{"key":"e_1_3_5_33_2","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G et al. The GRADE Handbook. Grading of Recommendations Assessment Development and Evaluation (GRADE) Working Group. 2013. Available from: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_3_5_35_2","first-page":"241","article-title":"Cochrane Statistical Methods Group","author":"Deeks JJ","year":"2019","unstructured":"Deeks JJ, , Higgins JP, , Altman DG. Cochrane Statistical Methods Group. Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, eds. Cochrane handbook for systematic reviews of interventions. Chichester, UK: John Wiley & Sons,, 2019; 241\u2013284.","journal-title":"Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, eds. Cochrane handbook for systematic reviews of interventions. Chichester, UK: John Wiley & Sons,"},{"key":"e_1_3_5_36_2","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) on behalf ofthe Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT Churchill R Chandler J Cumpston MS (editors) Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017) Cochrane 2017. Available from training.cochrane.org\/handbook."},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7521.903"},{"key":"e_1_3_5_38_2","doi-asserted-by":"crossref","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA editors. Cochrane handbook for systematic reviews of interventions. Chichester UK: John Wiley & Sons 2019.","DOI":"10.1002\/9781119536604"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(94)00117-4"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.2.567"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1997.13.305"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4154-9"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.1847"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2011.05.008"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2014.03.006"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv271"},{"key":"e_1_3_5_49_2","first-page":"7","article-title":"Loss to follow-up","volume":"2","author":"Dettori JR","year":"2011","unstructured":"Dettori JR. Loss to follow-up. Evidence Spince Care J. 2011; 2:7\u201310.","journal-title":"Evidence Spince Care J"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.131353"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d7762"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13710"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00776.x"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.140"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0363-2"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5080-4"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2018.0073"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.09.93"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2019.0218"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2019.0020"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000654"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-018-1761-x"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.1177\/0022042613511441"},{"key":"e_1_3_5_64_2","unstructured":"National Academies of Sciences Engineering and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. Challenges and Barriers in Conducting Cannabis Research. In: The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington DC: National Academies Press (US) 2017. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK425757\/"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.222"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125312457586"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2016.11.029"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2018.01969"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2016.00019"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00392-6"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00359"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2019.0016"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2019.29014.dpi"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94212-6"},{"key":"e_1_3_5_75_2","first-page":"100","article-title":"Keys to success with clinical trials","volume":"7","author":"Katz S","year":"2011","unstructured":"Katz S, , Dufficy H, , John C. Keys to success with clinical trials. J Gastroenterol Hepatol. 2011; 7:100\u2013105.","journal-title":"J Gastroenterol Hepatol"},{"key":"e_1_3_5_76_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12261"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2021.0048","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2021.0048","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2021.0048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:11:13Z","timestamp":1777385473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2021.0048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12,1]]}},"alternative-id":["10.1089\/can.2021.0048"],"URL":"https:\/\/doi.org\/10.1089\/can.2021.0048","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}